Common drugs linked to C. diff risk, study
-
April 13
“Given their high prevalence and strong associations with CDI, our findings underscore the importance of prudent prescribing and regular medication review."
Browse By
Biliary Tract
Colon
Esophagus
Liver
Pancreas
Small Bowel
Stomach
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists
-
February 1
-
by Raul S. Gonzalez, MD
Why better communication between gastroenterologists and pathologists matters for patient care.
Green endoscopy: Practical strategies to reduce environmental impact in GI practice
-
February 1
-
by Rabia de Latour, MD
There are plenty of opportunities for gastroenterologists, ambulatory surgery centers, endoscopy units, and outpatient clinics to implement changes that reduce GHG emissions.
The Latest
Diet, feeding route may influence bile acids in dysphagia
-
by Julia Cipriano
“We are excited that this study finally opens the door to modulate bile acids using nutritional interventions."
Common drugs linked to C. diff risk, study
-
by Doug Brunk
“Given their high prevalence and strong associations with CDI, our findings underscore the importance of prudent prescribing and regular medication review."
Heavy drinking tied to increased fibrosis risk in MASLD
-
by Olivia Anderson
"Episodic heavy drinking is an incredibly common pattern right now among US adults that even when it’s occasional, can be especially harmful."
Clinical practice update: Electrosurgery guidance refines endoscopy practice
-
by Doug Brunk
“An understanding of the principles of electrosurgery is fundamental for its safe and effective use."
No payoff found from higher doses in H. pylori treatment
-
by Doug Brunk
"When bismuth quadruple therapy was prescribed, increasing drug doses beyond the standard generally did not improve cure rates."
